MR-spectroscopy guided target delineation for high-grade gliomas

International Journal of Radiation Oncology Biology Physics

Volumn 50, Issue 4, 2001, Pages 915-928

  Pirzkall, Andrea ^a   McKnight, Tracy R ^a   Graves, Edward E ^a   Carol, Mark P ^b   Sneed, Penny K ^a   Wara, William W ^a   Nelson, Sarah J ^a   Verhey, Lynn J ^a   Larson, David A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Astrocytoma; Brain tumor; High grade glioma; Intensity modulated radiation therapy (IMRT); Magnetic resonance imaging (MRI); MR spectroscopy (MRSI)

Indexed keywords

BRAIN; MAGNETIC RESONANCE IMAGING; METABOLISM; RADIOTHERAPY; SPECTROSCOPY; TUMORS;

HIGH-GRADE GLIOMAS; NECROSIS;

ONCOLOGY;

ADULT; ARTICLE; ASTROCYTOMA; CANCER RADIOTHERAPY; CLINICAL ARTICLE; GLIOMA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR VOLUME; VOLUMETRY;

ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 0035879639     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01548-6     Document Type: Article

References (55)

1. Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors
2. Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas
3. Malignant astrocytomas; focal tumor recurrence after focal external beam radiation therapy
4. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma
5. High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme
6. Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme; results of a phase II prospective trial
7. Localized high-resolution proton NMR spectroscopy using stimulated echoes; Initial applications to human brain in vivo
8. 3D phase encoding 1H spectroscopic imaging of human brain
9. Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy
10. Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading
11. In vivo magnetic resonance spectroscopy of human brain tumors
12. Added value of automated clinical proton MR spectroscopy of the brain
13. Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast
14. Proton magnetic resonance spectroscopy in patients with glial tumors; A multicenter study
15. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy
16. Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis
17. Differentiation of cerebral radiation necrosis from tumor recurrence by proton magnetic resonance spectroscopy
18. A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas
19. An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma
20. Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas; A quantitative dosimetric study
21. Stereotactic histologic correlations of computed tomography-and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms
22. The growth of glioblastoma multiforme (astrocytomas grades 3 and 4) in neurosurgical practice
23. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme
24. Assumptions in the radiotherapy of glioblastoma
25. 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation
26. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms
27. Radiation therapy treatment planning in supratentorial glioblastoma multiforme; An analysis based on post mortem topographic anatomy with CT correlations
28. Cerebral radionecrosis; incidence and risk in relation to dose, time, fractionation and volume
29. Neuropsychologic impairment in adults with brain tumors
30. The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas
31. First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas
32. Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference
33. Cerebral glioma; evaluation with methionine PET
34. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo; Initial experience in patients with cerebral tumors
35. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy
36. Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors
37. Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy
38. NMR chemical shift imaging in 3 dimensions
39. Detection of metabolic heterogeneity of human intracranial tumors in vivo by 1H NMR spectroscopic imaging
40. Mapping of brain tumor metabolites with proton MR spectroscopic imaging; Clinical relevance
41. High spatial resolution 1H-MRSI and segmented MRI of cortical gray matter and subcortical white matter in three regions of the human brain
42. Metabolic imaging of patients with intracranial tumors; H-1 MR spectroscopic imaging and PET
43. Absolute concentrations of metabolites in the adult human brain in vivo; Quantification of localized proton MR spectra
44. Central nervous system trans-synaptic effects of acute axonal injury; A 1H magnetic resonance spectroscopy study
45. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy
46. Volume MRI, and MRSI techniques for the quantitation of treatment response in brain tumors. Presentation of a detailed case study
47. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy
48. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer
49. Towards multidimensional radiotherapy (MD-CRT); biological imaging and biological conformality